FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.

K Kaczirek; TE Ciuleanu; D Vrbanec; E Marton; D Messinger; Bernadette Liegl-Atzwanger; F Wrba; R Knittelfelder; E Lindner; CC Zielinski; B Streubel; T Brodowicz

doi:10.1016/j.clcc.2014.12.003

FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.

K Kaczirek
, TE Ciuleanu
, D Vrbanec
, E Marton
, D Messinger
, Bernadette Liegl-Atzwanger
, F Wrba
, R Knittelfelder
, E Lindner
, CC Zielinski
, B Streubel
, T Brodowicz

Diagnostic and Research Institute of Pathology

Research output: Contribution to journal › Research article

26 Citations (Web of Science)

Original language	English
Journal	Clinical Colorectal Cancer
DOIs	https://doi.org/10.1016/j.clcc.2014.12.003
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

301 Medical-Theoretical Sciences, Pharmacy

Research Fields

Cancer Research

DOI

10.1016/j.clcc.2014.12.003

Links

Cite this

Kaczirek, K., Ciuleanu, TE., Vrbanec, D., Marton, E., Messinger, D., Liegl-Atzwanger, B., Wrba, F., Knittelfelder, R., Lindner, E., Zielinski, CC., Streubel, B., & Brodowicz, T. (2015). FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2014.12.003

@article{ad617e670cf245d5b6aebd17b8f43785,

title = "FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.",

author = "K Kaczirek and TE Ciuleanu and D Vrbanec and E Marton and D Messinger and Bernadette Liegl-Atzwanger and F Wrba and R Knittelfelder and E Lindner and CC Zielinski and B Streubel and T Brodowicz",

year = "2015",

doi = "10.1016/j.clcc.2014.12.003",

language = "English",

journal = "Clinical Colorectal Cancer",

issn = "1533-0028",

publisher = "Elsevier Inc.",

}

Kaczirek, K, Ciuleanu, TE, Vrbanec, D, Marton, E, Messinger, D, Liegl-Atzwanger, B, Wrba, F, Knittelfelder, R, Lindner, E, Zielinski, CC, Streubel, B & Brodowicz, T 2015, 'FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.', Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2014.12.003

TY - JOUR

T1 - FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.

AU - Kaczirek, K

AU - Ciuleanu, TE

AU - Vrbanec, D

AU - Marton, E

AU - Messinger, D

AU - Liegl-Atzwanger, Bernadette

AU - Wrba, F

AU - Knittelfelder, R

AU - Lindner, E

AU - Zielinski, CC

AU - Streubel, B

AU - Brodowicz, T

PY - 2015

Y1 - 2015

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000355157600004

UR - https://pubmed.ncbi.nlm.nih.gov/25666295

U2 - 10.1016/j.clcc.2014.12.003

DO - 10.1016/j.clcc.2014.12.003

M3 - Research article

C2 - 25666295

SN - 1533-0028

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

ER -